Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| AVR | ANTERIS TECHNOLOGIES GLOBAL CORP | $113.11M | 36,023,796 | 45.16% | 0.21% | Net Buying | Net Buying | ||
| IBKR | INTERACTIVE BROKERS GROUP INC | $16.72B | 108,931,614 | 84.62% | 15.38% | Net Buying | Net Buying | ||
| RWAY | RUNWAY GROWTH FINANCE CORP | $337.25M | 37,347,428 | 39.65% | 60.35% | Net Selling | Net Selling | ||
| LXEO | LEXEO THERAPEUTICS INC | $106.56M | 33,196,997 | 80.55% | 19.45% | Net Selling | Net Buying | ||
| VYGR | VOYAGER THERAPEUTICS INC | $177.21M | 55,206,885 | 53.96% | 46.04% | Net Selling | Net Selling | ||
| CTNM | CONTINEUM THERAPEUTICS INC | $128.06M | 25,871,549 | 61.00% | 10.44% | Net Buying | |||
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | $15.09B | 1,133,838,689 | 58.60% | 0.82% | Net Selling | Net Selling | ||
| EVH | EVOLENT HEALTH INC | $988.69M | 116,591,148 | 88.98% | 11.02% | Net Selling | Net Selling | ||
| ELVN | ENLIVEN THERAPEUTICS INC | $794.85M | 49,004,425 | 44.92% | 55.08% | Net Selling | Net Selling | ||
| TNGX | TANGO THERAPEUTICS INC | $149.19M | 108,107,890 | 55.24% | 44.76% | Net Selling | Net Selling | ||
| GHRS | GH RESEARCH PLC | $477.10M | 52,028,145 | 59.00% | 0.00% | ||||
| JAKK | JAKKS PACIFIC INC | $201.64M | 11,146,230 | 21.55% | 78.45% | Net Buying | Net Buying | ||
| OTLY | OATLY GROUP AB | $255.29M | 598,559,840 | 13.35% | 0.00% | ||||
| APGE | APOGEE THERAPEUTICS INC | $1.95B | 59,503,184 | 90.99% | 9.01% | Net Selling | Net Selling | ||
| HUMA | HUMACYTE INC | $224.92M | 155,118,816 | 27.13% | 22.31% | Net Selling | Net Buying | ||
| TSHA | TAYSHA GENE THERAPIES INC | $297.25M | 205,001,632 | 81.51% | 15.27% | Net Buying | Net Selling | ||
| XNCR | XENCOR INC | $746.90M | 70,461,934 | 70.29% | 29.71% | Net Selling | Net Selling | ||
| PASG | PASSAGE BIO INC | $22.25M | 62,148,274 | 44.69% | 55.31% | Net Selling | Net Selling | ||
| LENZ | LENZ THERAPEUTICS INC | $664.06M | 27,542,874 | 38.92% | 61.08% | Net Buying | Net Buying | ||
| IAC | IAC INC | $2.74B | 83,283,336 | 83.38% | 3.29% | Net Buying | Net Buying | ||
| STRW | STRAWBERRY FIELDS REIT INC | $134.76M | 12,217,351 | 24.49% | 36.77% | Net Buying | Net Buying | ||
| ALXO | ALX ONCOLOGY HOLDINGS INC | $30.22M | 53,384,145 | 73.37% | 26.63% | Net Buying | Net Selling | ||
| FCNCA | FIRST CITIZENS BANCSHARES INC | $22.87B | 13,577,248 | 36.84% | 63.16% | Net Selling | Net Buying | ||
| FLL | FULL HOUSE RESORTS INC | $104.76M | 35,875,647 | 42.99% | 57.01% | Net Buying | Net Buying | ||
| ATUS | ALTICE USA INC | $1.02B | 463,230,046 | 29.33% | 70.67% | Net Selling | Net Selling | ||
| RGLS | REGULUS THERAPEUTICS INC | $133.15M | 66,243,384 | 23.05% | 76.95% | Net Buying | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.